TLX

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Telix Pharmaceuticals Limited

NASDAQ | TLX

10.03

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 14, 2025)

$5.23B

Market Cap

173.44

P/E Ratio

0.09

EPS

$30.36

52 Week High

$8.93

52 Week Low

HEALTHCARE

Sector

TLX Chart

Recent Chart
Price Action

TLX Technicals

Tags:

TLX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (AUD)
Gross Profit $510M
Total Revenue $783M
Cost Of Revenue $274M
Costof Goods And Services Sold $274M
Operating Income $82M
Selling General And Administrative $122M
Research And Development $121M
Operating Expenses $428M
Investment Income Net -
Net Interest Income -$26M
Interest Income $11M
Interest Expense $21M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.7M
Income Before Tax $56M
Income Tax Expense $6.1M
Interest And Debt Expense -
Net Income From Continuing Operations $50M
Comprehensive Income Net Of Tax -
Ebit $87M
Ebitda $93M
Net Income $50M

Revenue & Profitability

Earnings Performance

TLX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (AUD)
Total Assets $1.5B
Total Current Assets $919M
Cash And Cash Equivalents At Carrying Value $710M
Cash And Short Term Investments $710M
Inventory $38M
Current Net Receivables $159M
Total Non Current Assets $598M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $309M
Intangible Assets Excluding Goodwill $309M
Goodwill $107M
Investments -
Long Term Investments $6.1M
Short Term Investments -
Other Current Assets $11M
Other Non Current Assets -
Total Liabilities $948M
Total Current Liabilities $331M
Current Accounts Payable $69M
Deferred Revenue -
Current Debt -
Short Term Debt $21M
Total Non Current Liabilities $617M
Capital Lease Obligations $11M
Long Term Debt $552M
Current Long Term Debt $19M
Long Term Debt Noncurrent -
Short Long Term Debt Total $581M
Other Current Liabilities $181M
Other Non Current Liabilities $30M
Total Shareholder Equity $568M
Treasury Stock -
Retained Earnings -$213M
Common Stock $597M
Common Stock Shares Outstanding $345M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (AUD)
Operating Cashflow $43M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -
Capital Expenditures $34M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$135M
Cashflow From Financing $639M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $50M

yearly Income Statement (As of Dec 31, 2024)

Field Value (AUD)
Gross Profit $510M
Total Revenue $783M
Cost Of Revenue $274M
Costof Goods And Services Sold $274M
Operating Income $82M
Selling General And Administrative $122M
Research And Development $121M
Operating Expenses $428M
Investment Income Net -
Net Interest Income -$26M
Interest Income $11M
Interest Expense $21M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.7M
Income Before Tax $56M
Income Tax Expense $6.1M
Interest And Debt Expense -
Net Income From Continuing Operations $50M
Comprehensive Income Net Of Tax -
Ebit $87M
Ebitda $93M
Net Income $50M

TLX News

TLX Profile

Telix Pharmaceuticals Limited Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Telix Pharmaceuticals Limited is an innovative commercial-stage biopharmaceutical company dedicated to advancing the field of radiopharmaceuticals for the diagnosis and treatment of cancer and rare diseases. With its headquarters in North Melbourne, Australia, Telix operates in key markets including the United States, Belgium, Japan, and Switzerland, leveraging its expertise to deliver cutting-edge therapeutic and diagnostic solutions. The company's strategic focus on unmet medical needs underscores its commitment to improving patient outcomes through targeted therapies, positioning it as a promising player in the evolving biopharmaceutical landscape.

VHAI
+66.66%
$0.00
YYAI
-11.76%
$0.15
BURU
-20.39%
$0.40
UGRO
+54.52%
$0.57
NVDA
-4.40%
$180.03
CGBS
-39.47%
$0.03
PLUG
+3.84%
$4.05
BITF
+28.33%
$5.39
NVTS
+26.07%
$12.57
TMQ
+59.90%
$10.49
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.57%
$3.19
LAES
+24.79%
$7.65
INTC
-4.27%
$35.63
BYND
-24.56%
$0.78
JOBY
+8.05%
$18.12
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.05%
$0.34
F
+1.08%
$11.66
EDHL
+114.42%
$1.07
CRML
+28.73%
$29.97
WULF
+10.42%
$15.46
ACHR
+1.91%
$13.01
SOUN
+8.98%
$20.86
BBD
+1.94%
$3.15
NAK
+4.13%
$2.76
TLRY
-5.32%
$1.60
DVLT
+24.76%
$2.12
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
QBTS
+6.00%
$43.06
GPUS
-5.58%
$0.40
TSLA
-1.52%
$429.24
MARA
+9.88%
$22.24
AMD
+0.77%
$218.09
SOFI
+2.68%
$27.87
AXDX
-61.36%
$0.03
MNTS
+19.58%
$1.71
CLF
+0.94%
$13.96
QS
+15.57%
$16.98
ERIC
+20.56%
$9.85
RIG
-2.65%
$3.11
ETHD
+6.60%
$3.55
CIFR
+2.70%
$20.89
NIO
-5.15%
$6.81
QUBT
+1.49%
$21.78
NUAI
+30.63%
$3.07
UAMY
+4.54%
$17.47
NOK
+4.28%
$5.47
CLSK
+9.68%
$21.98
ASST
-7.69%
$0.99
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
IREN
+8.16%
$69.37
AREC
+36.74%
$6.81
ADAP
-11.16%
$0.16
ABAT
+36.59%
$9.22
RF
+2.44%
$25.16
BTG
+0.56%
$5.34
JDZG
+59.57%
$3.00
WWR
+35.93%
$3.48
AAL
+1.90%
$11.74
USAR
-2.72%
$37.62
UUUU
+16.86%
$23.77
PFE
-0.82%
$24.52
BAC
+2.45%
$50.06
SNAP
-1.61%
$7.92
BMNR
-6.84%
$52.96
RMBL
+60.50%
$3.21
MP
+3.77%
$98.65
AMZN
-1.69%
$216.34
T
+2.11%
$26.13
ADD
-25.47%
$0.05
BCRX
-8.80%
$6.42
JBLU
+7.91%
$4.91
WFC
+7.14%
$84.56
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
ATXS
+37.07%
$11.61
HPE
+0.80%
$25.00
AQMS
+198.89%
$29.62
IONQ
-5.53%
$77.55
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDLY
-7.78%
$0.78
VALE
-0.36%
$10.97
C
+3.89%
$99.84
KDP
+2.32%
$26.42
RGTZ
-5.37%
$8.80
GRAB
-0.33%
$5.91
HOOD
-4.07%
$134.94
BULL
-0.08%
$11.73
GWH
-16.24%
$7.58
DFLI
-2.54%
$1.53
ABEV
+1.16%
$2.16
NB
+3.09%
$11.67
VHAI
+66.66%
$0.00
YYAI
-11.76%
$0.15
BURU
-20.39%
$0.40
UGRO
+54.52%
$0.57
NVDA
-4.40%
$180.03
CGBS
-39.47%
$0.03
PLUG
+3.84%
$4.05
BITF
+28.33%
$5.39
NVTS
+26.07%
$12.57
TMQ
+59.90%
$10.49
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.57%
$3.19
LAES
+24.79%
$7.65
INTC
-4.27%
$35.63
BYND
-24.56%
$0.78
JOBY
+8.05%
$18.12
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.05%
$0.34
F
+1.08%
$11.66
EDHL
+114.42%
$1.07
CRML
+28.73%
$29.97
WULF
+10.42%
$15.46
ACHR
+1.91%
$13.01
SOUN
+8.98%
$20.86
BBD
+1.94%
$3.15
NAK
+4.13%
$2.76
TLRY
-5.32%
$1.60
DVLT
+24.76%
$2.12
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
QBTS
+6.00%
$43.06
GPUS
-5.58%
$0.40
TSLA
-1.52%
$429.24
MARA
+9.88%
$22.24
AMD
+0.77%
$218.09
SOFI
+2.68%
$27.87
AXDX
-61.36%
$0.03
MNTS
+19.58%
$1.71
CLF
+0.94%
$13.96
QS
+15.57%
$16.98
ERIC
+20.56%
$9.85
RIG
-2.65%
$3.11
ETHD
+6.60%
$3.55
CIFR
+2.70%
$20.89
NIO
-5.15%
$6.81
QUBT
+1.49%
$21.78
NUAI
+30.63%
$3.07
UAMY
+4.54%
$17.47
NOK
+4.28%
$5.47
CLSK
+9.68%
$21.98
ASST
-7.69%
$0.99
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
IREN
+8.16%
$69.37
AREC
+36.74%
$6.81
ADAP
-11.16%
$0.16
ABAT
+36.59%
$9.22
RF
+2.44%
$25.16
BTG
+0.56%
$5.34
JDZG
+59.57%
$3.00
WWR
+35.93%
$3.48
AAL
+1.90%
$11.74
USAR
-2.72%
$37.62
UUUU
+16.86%
$23.77
PFE
-0.82%
$24.52
BAC
+2.45%
$50.06
SNAP
-1.61%
$7.92
BMNR
-6.84%
$52.96
RMBL
+60.50%
$3.21
MP
+3.77%
$98.65
AMZN
-1.69%
$216.34
T
+2.11%
$26.13
ADD
-25.47%
$0.05
BCRX
-8.80%
$6.42
JBLU
+7.91%
$4.91
WFC
+7.14%
$84.56
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
ATXS
+37.07%
$11.61
HPE
+0.80%
$25.00
AQMS
+198.89%
$29.62
IONQ
-5.53%
$77.55
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDLY
-7.78%
$0.78
VALE
-0.36%
$10.97
C
+3.89%
$99.84
KDP
+2.32%
$26.42
RGTZ
-5.37%
$8.80
GRAB
-0.33%
$5.91
HOOD
-4.07%
$134.94
BULL
-0.08%
$11.73
GWH
-16.24%
$7.58
DFLI
-2.54%
$1.53
ABEV
+1.16%
$2.16
NB
+3.09%
$11.67
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.